SCHEMBL16092552

SCHEMBL16092552

CC(C)c1c(-c2cccc(C(N)=O)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.37
▸ KDM5A P29375 5/20 0.37
▸ KDM5B Q9UGL1 3/20 0.37
▸ KDM6B O15054 1/20 0.37
▸ KDM5C P41229 1/20 0.37
▸ KDM5D Q9BY66 1/20 0.37
▸ KDM4C Q9H3R0 1/20 0.37
▸ PHF8 Q9UPP1 1/20 0.37
▸ ADORA1 P30542 1/20 0.36
▸ KDM4D Q6B0I6 1/20 0.36
▸ FYN P06241 2/20 0.36
▸ PARP1 P09874 2/20 0.36
▸ CYP11B2 P19099 1/20 0.35
▸ CDC7 O00311 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.34
▸ TGFBR1 P36897 1/20 0.34
▸ PIK3R2 O00459 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092445 0.88 KDM5A (0.36) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17085740 0.87 KDM5A (0.39) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16092426 0.86 CYP11B2 (0.38) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16092280 0.86 TTK (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092493 0.86 KDM5B (0.48) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16092243 0.86 KDM5A (0.43) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092293 0.86 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092428 0.86 KDM5A (0.38) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17547869 0.85 TLR8 (0.47) PARP1CYP11B2
SCHEMBL16050761 0.85 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B BRD4 71/4885KDM5A 1/4885KDM5B 3/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B BRD4 71/4885KDM5A 1/4885KDM5B 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback